Cargando…

The Impact of SARS-CoV-2 Infection in Unvaccinated Multiple Sclerosis Patients on Disease-Modifying Therapies

OBJECTIVE: Disease-modifying therapies (DMTs) in multiple sclerosis (MS) may affect the course and outcome of COVID-19, but withholding them could permit disease activity. This study aimed to understand the course of COVID-19 in unvaccinated patients with MS on disease-modifying therapies. SUBJECTS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Al-Shammri, Suhail, Chadha, Geeti, Chattopadhyay, Arpita, Doi, Suhail
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2023
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10319087/ https://www.ncbi.nlm.nih.gov/pubmed/37231972 http://dx.doi.org/10.1159/000530764

Ejemplares similares

Association of Blood Levels of Vitamin D and Its Binding Protein with Clinical Phenotypes of Multiple Sclerosis
por: Al-Shammri, Suhail, et al.
Publicado: (2023)

Sociocultural and Demographic Risk Factors for the Development of Multiple Sclerosis in Kuwait: A Case - Control Study
por: Al-Shammri, Suhail N., et al.
Publicado: (2015)

Distribution of vitamin D‐binding protein/group‐specific component gene subtypes in Kuwaiti population
por: Al‐Shammri, Suhail Najim, et al.
Publicado: (2022)

SARS-CoV-2 and Its Variants: The Pandemic of Unvaccinated
por: Angius, Fabrizio, et al.
Publicado: (2021)

Viral Dynamics of SARS-CoV-2 Variants in Vaccinated and Unvaccinated Persons
por: Kissler, Stephen M., et al.
Publicado: (2021)

Placental pathology in women vaccinated and unvaccinated against SARS-CoV-2
por: Smithgall, Marie C., et al.
Publicado: (2022)

SARS-CoV-2 Seroprevalence in Unvaccinated Adults in Thailand in November 2021
por: Mahasirimongkol, Surakameth, et al.
Publicado: (2022)

SARS-CoV-2 Placental Infection in an Unvaccinated Mother Resulting in Fetal Demise
por: Bewley, Dominic J, et al.
Publicado: (2021)

Unvaccinated patients may still experience SARS-CoV-2 associated polyradiculitis
por: Finsterer, Josef
Publicado: (2022)

Transmission and Infectious SARS-CoV-2 Shedding Kinetics in Vaccinated and Unvaccinated Individuals
por: Jung, Jiwon, et al.
Publicado: (2022)

Incorporating and addressing testing bias within estimates of epidemic dynamics for SARS-CoV-2
por: Suhail, Yasir, et al.
Publicado: (2021)

SARS-CoV-2 Transmission and Impacts of Unvaccinated-Only Screening in Populations of Mixed Vaccination Status
por: Bubar, Kate M., et al.
Publicado: (2022)

SARS-CoV-2 transmission and impacts of unvaccinated-only screening in populations of mixed vaccination status
por: Bubar, Kate M., et al.
Publicado: (2022)

Disease-modifying therapies and SARS-CoV-2 vaccination in multiple sclerosis: an expert consensus
por: Centonze, Diego, et al.
Publicado: (2021)

Response to SARS-CoV-2 vaccination in multiple sclerosis patients on disease modifying therapies
por: Allman, M., et al.
Publicado: (2022)

Natural immunity to SARS-CoV-2 and breakthrough infections in vaccinated and unvaccinated patients with cancer
por: Cortellini, Alessio, et al.
Publicado: (2022)

Antibodies to NCP, RBD and S2 SARS-CoV-2 in Vaccinated and Unvaccinated Healthcare Workers
por: Błaszczuk, Agata, et al.
Publicado: (2022)

Effectiveness of prevention of SARS-CoV-2 transmission among unvaccinated Italian healthcare workers
por: Collatuzzo, Giulia, et al.
Publicado: (2022)

SARS-CoV-2 viral shedding in vaccinated and unvaccinated persons: A case series
por: McCormick, David W., et al.
Publicado: (2023)

Within-host genetic diversity of SARS-CoV-2 lineages in unvaccinated and vaccinated individuals
por: Gu, Haogao, et al.
Publicado: (2023)

Impact of Disease-Modifying Treatments of Multiple Sclerosis on Anti–SARS-CoV-2 Antibodies: An Observational Study
por: Bigaut, Kévin, et al.
Publicado: (2021)

Ancestral SARS-CoV-2-Driven Antibody Repertoire Diversity in an Unvaccinated Individual Correlates with Expanded Neutralization Breadth
por: Deshpande, Suprit, et al.
Publicado: (2023)

SARS-CoV-2 Antinucleocapsid Antibody Response of mRNA and Inactivated Virus Vaccines Compared to Unvaccinated Individuals
por: Qaqish, Arwa, et al.
Publicado: (2022)

SARS-CoV-2/COVID-19 in multiple sclerosis patients receiving disease-modifying therapy
por: Adamczyk-Sowa, Monika, et al.
Publicado: (2021)

Safety of disease-modifying treatments in SARS-CoV-2 antibody-positive multiple sclerosis patients
por: Mallucci, Giulia, et al.
Publicado: (2021)

T cell responses to SARS-CoV-2 vaccination differ by disease-modifying therapy for multiple sclerosis
por: Wolf, Asia-Sophia, et al.
Publicado: (2023)

Multiple sclerosis following SARS-CoV-2 infection
por: Palao, M., et al.
Publicado: (2020)

SARS-CoV-2 triggered relapse of multiple sclerosis
por: Finsterer, Josef
Publicado: (2022)

Role of Oxidative Stress on SARS-CoV (SARS) and SARS-CoV-2 (COVID-19) Infection: A Review
por: Suhail, Shanzay, et al.
Publicado: (2020)

Assessment of Clinical Profile and Treatment Outcome in Vaccinated and Unvaccinated SARS-CoV-2 Infected Patients
por: Korishettar, Ganesh, et al.
Publicado: (2022)

Impact of multiple sclerosis disease-modifying therapies on SARS-CoV-2 vaccine-induced antibody and T cell immunity
por: Sabatino, Joseph J., et al.
Publicado: (2021)

The Impact of SARS-CoV-2 Infection on the Development of Neurodegeneration in Multiple Sclerosis
por: Dziedzic, Angela, et al.
Publicado: (2021)

SARS-CoV-2 Infection: Modulator of Pulmonary Embolism Paradigm
por: Akhter, Mohammad Suhail, et al.
Publicado: (2021)

Household transmission of SARS-CoV-2 from unvaccinated asymptomatic and symptomatic household members with confirmed SARS-CoV-2 infection: an antibody-surveillance study
por: Bhatt, Maala, et al.
Publicado: (2022)

Relative Virulence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Among Vaccinated and Unvaccinated Individuals Hospitalized With SARS-CoV-2
por: Grima, Alicia A, et al.
Publicado: (2022)

Seroprevalence of SARS-CoV-2 in a Cohort of Patients with Multiple Sclerosis under Disease-Modifying Therapies
por: Sancho-Saldaña, Agustín, et al.
Publicado: (2022)

Vitamin D Status and Mortality from SARS CoV-2: A Prospective Study of Unvaccinated Caucasian Adults
por: Barrett, Robert, et al.
Publicado: (2022)

Multiple Sclerosis and SARS-CoV-2: Has the Interplay Started?
por: Bellucci, Gianmarco, et al.
Publicado: (2021)

Approach to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis
por: Woopen, Christina, et al.
Publicado: (2021)

SARS-CoV-2 Infection and Risk Management in Multiple Sclerosis
por: Diaz de la Fe, Amado, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6aobot6s2t1nn0thqkrl2p2u00